A Bioequivalence Study of Tobradex AF

Alcon Research995 enrolled

Overview

The purpose of the study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

995

Conditions

Cataract

Interventions

Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspensionDRUG

One drop in the study eye, single dose

Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)DRUG

One drop in the study eye, single dose

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 or older * Other protocol-defined inclusion criteria may apply Exclusion Criteria: * Under 18 * Other protocol-defined exclusion criteria may apply

Locations (1)

Contact Alcon for Trial Location(s)

Fort Worth, Texas, United States

Outcomes

Primary Outcomes

Concentration of dexamethasone in aqueous humor following a single topical ocular administration

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.